The US kratom industry sees the short period the Food and Drug Administration allowed for comments on whether kratom should be added to the United Nations’ schedule of controlled substances as another example of the agency’s refusal to consider the botanical’s safety and benefits.
The American Kratom Association didn’t convince a federal judge on 9 August to order the FDA to extend from that...





